B
18.00
-0.17 (-0.94%)
| Previous Close | 18.17 |
| Open | 18.17 |
| Volume | 503,756 |
| Avg. Volume (3M) | 403,170 |
| Market Cap | 983,024,576 |
| Price / Book | 2.10 |
| 52 Weeks Range | |
| Earnings Date | 11 Nov 2025 |
| Diluted EPS (TTM) | -1.69 |
| Total Debt/Equity (MRQ) | 0.13% |
| Current Ratio (MRQ) | 24.62 |
| Operating Cash Flow (TTM) | -88.27 M |
| Levered Free Cash Flow (TTM) | -53.72 M |
| Return on Assets (TTM) | -13.84% |
| Return on Equity (TTM) | -27.26% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Bicara Therapeutics Inc. | Bullish | - |
AIStockmoo Score
0.1
| Analyst Consensus | 3.0 |
| Insider Activity | -3.5 |
| Price Volatility | -1.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | 0.10 |
|
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 11.65% |
| % Held by Institutions | 89.28% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Red Tree Management, Llc | 30 Jun 2025 | 3,170,509 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 40.00 (HC Wainwright & Co., 122.22%) | Buy |
| Median | 38.00 (111.11%) | |
| Low | 36.00 (Piper Sandler, 100.00%) | Buy |
| Average | 38.00 (111.11%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 11.68 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 22 Aug 2025 | 40.00 (122.22%) | Buy | 11.84 |
| Piper Sandler | 19 Aug 2025 | 36.00 (100.00%) | Buy | 11.51 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| COHLHEPP RYAN | - | 18.81 | -12,500 | -235,125 |
| HYEP IVAN | - | 18.26 | -6,415 | -117,138 |
| MAZUMDAR CLAIRE | - | 18.66 | -24,734 | -461,813 |
| RABEN DAVID | - | 18.26 | -22,000 | -401,720 |
| Aggregate Net Quantity | -65,649 | |||
| Aggregate Net Value ($) | -1,215,796 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 18.53 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| MAZUMDAR CLAIRE | Officer | 15 Oct 2025 | Automatic sell (-) | 13,289 | 18.81 | 249,966 |
| MAZUMDAR CLAIRE | Officer | 15 Oct 2025 | Option execute | 13,289 | - | - |
| COHLHEPP RYAN | Officer | 15 Oct 2025 | Automatic sell (-) | 12,500 | 18.81 | 235,125 |
| COHLHEPP RYAN | Officer | 15 Oct 2025 | Option execute | 8,000 | - | - |
| MAZUMDAR CLAIRE | Officer | 13 Oct 2025 | Automatic sell (-) | 11,445 | 18.51 | 211,847 |
| MAZUMDAR CLAIRE | Officer | 13 Oct 2025 | Option execute | 11,445 | - | - |
| HYEP IVAN | Officer | 09 Oct 2025 | Automatic sell (-) | 6,415 | 18.26 | 117,138 |
| HYEP IVAN | Officer | 09 Oct 2025 | Option execute | 6,415 | - | - |
| RABEN DAVID | Officer | 09 Oct 2025 | Automatic sell (-) | 22,000 | 18.26 | 401,720 |
| RABEN DAVID | Officer | 09 Oct 2025 | Option execute | 22,000 | - | - |
| Date | Type | Details |
|---|---|---|
| 13 Oct 2025 | Announcement | Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC |
| 27 Aug 2025 | Announcement | Bicara Therapeutics to Participate in Upcoming Investor Conferences |
| 12 Aug 2025 | Announcement | Bicara Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |